Education
About Us
Working with TipRanks
Follow Us
Zimmer Biomet Holdings (ZBH)
NYSE:ZBH
ZBH Stock Chart & Stats
$89.07
-$1.23(-1.19%)
At close: 4:00 PM EST
$89.07
-$1.23(-1.19%)
Day’s Range― - ―
52-Week Range$85.33 - $114.44
Previous CloseN/A
Volume487.31K
Average Volume (3M)2.06M
Market Cap
$17.73B
Enterprise Value$26.41B
Total Cash (Recent Filing)$1.29B
Total Debt (Recent Filing)$8.11B
Price to Earnings (P/E)22.1
Beta0.56
Next Earnings
Feb 05, 2026EPS Estimate
2.4Last Dividend Ex-Date
Sep 30, 2025Dividend Yield1.07%
Share Statistics
EPS (TTM)1.90
Shares Outstanding198,181,550
10 Day Avg. Volume2,427,977
30 Day Avg. Volume2,058,884
Financial Highlights & Ratios
PEG Ratio-2.53
Price to Book (P/B)1.72
Price to Sales (P/S)2.79
P/FCF Ratio18.78
Enterprise Value/Market Cap1.49
Enterprise Value/Revenue3.30
Enterprise Value/Gross Profit4.61
Enterprise Value/Ebitda11.11
Forecast
1Y Price Target
$103.38Price Target Upside16.07% Upside
Rating ConsensusHold
Number of Analyst Covering19
EPS Forecast (FY)8.17
Revenue Forecast (FY)$8.21B
Bulls Say, Bears Say
Bulls Say
Acquisition ImpactThe FNA acquisition is expected to contribute approximately 270 basis points to growth, indicating a positive impact from strategic acquisitions.
Foreign Exchange ContributionForeign exchange is now expected to contribute 50-100 basis points to reported growth, an increase from the previous expectation of around 50 basis points.
Product InnovationZimmer Biomet’s multiple waves of new product innovation are moving forward positively.
Bears Say
Emerging Markets PerformanceZBH experienced headwinds in its Emerging Markets/Latam and Restorative Therapies businesses, impacting its growth by 120bps.
Market Share LossZBH's recon share was down as it lost share in both knee and hip markets.
Revenue Growth GuidanceThe revenue growth guidance for FY25 has been tightened, suggesting a more conservative outlook on revenue increase.
Zimmer Biomet Holdings News
ZBH FAQ
What was Zimmer Biomet Holdings’s price range in the past 12 months?
Zimmer Biomet Holdings lowest stock price was $85.33 and its highest was $114.44 in the past 12 months.
What is Zimmer Biomet Holdings’s market cap?
Zimmer Biomet Holdings’s market cap is $17.73B.
When is Zimmer Biomet Holdings’s upcoming earnings report date?
Zimmer Biomet Holdings’s upcoming earnings report date is Feb 05, 2026 which is in 76 days.
How were Zimmer Biomet Holdings’s earnings last quarter?
Zimmer Biomet Holdings released its earnings results on Nov 05, 2025. The company reported $1.9 earnings per share for the quarter, beating the consensus estimate of $1.866 by $0.034.
Is Zimmer Biomet Holdings overvalued?
According to Wall Street analysts Zimmer Biomet Holdings’s price is currently Undervalued.
Does Zimmer Biomet Holdings pay dividends?
Zimmer Biomet Holdings pays a Quarterly dividend of $0.24 which represents an annual dividend yield of 1.07%. See more information on Zimmer Biomet Holdings dividends here
What is Zimmer Biomet Holdings’s EPS estimate?
Zimmer Biomet Holdings’s EPS estimate is 2.4.
How many shares outstanding does Zimmer Biomet Holdings have?
Zimmer Biomet Holdings has 198,181,550 shares outstanding.
What happened to Zimmer Biomet Holdings’s price movement after its last earnings report?
Zimmer Biomet Holdings reported an EPS of $1.9 in its last earnings report, beating expectations of $1.866. Following the earnings report the stock price went down -15.148%.
Which hedge fund is a major shareholder of Zimmer Biomet Holdings?
Currently, no hedge funds are holding shares in ZBH
Zimmer Biomet Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$103.38 (16.07% Upside)
$103.38 (16.07% Upside)
Blogger Sentiment
Bullish
ZBH Sentiment 100%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Increased
By 698.7K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $156.2K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Negative
Last 7 Days ▲ 1.5%
Last 30 Days ▲ 0.2%
Last 30 Days ▲ 0.2%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-17.71%
12-Months-Change
Fundamentals
Return on Equity
6.41%
Trailing 12-Months
Asset Growth
8.14%
Trailing 12-Months
Company Description
Zimmer Biomet Holdings
Zimmer Biomet Holdings (ZBH) is a global leader in musculoskeletal healthcare, specializing in the design, manufacture, and marketing of orthopedic implants, surgical instruments, and related products. The company operates in various sectors, including reconstructive orthopedics, dental implants, and spine surgery. Zimmer Biomet's core products encompass knee, hip, and extremities implants, along with dental solutions and surgical robotics, aimed at enhancing patient mobility and quality of life.
ZBH Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Neutral
The earnings call presented a mixed picture with significant growth in the U.S. and technological advancements, but also highlighted challenges in emerging markets and specific segments, leading to a cautious adjustment in revenue guidance.View all ZBH earnings summariesZBH Net sales Breakdown
41.33% Knees
26.03% Hips
24.30% S.E.T
8.34% Technology & Data, Bone Cement and Surgical
ZBH Stock 12 Month Forecast
Average Price Target
$103.38
▲(16.07% Upside)
Technical Analysis
Ownership Overview
Currently, No data available
---